Importantly this particular mutation is almost restricted to the hematopoietic lineage and previous publications have shown that ASXL1 mutations have prognostic impact in patients with MDS [5] and AML [3, 6]. The gene discussed is ASXL1; the disease is myelodysplastic syndrome.